0.360
-0.01 (-2.70%)
| Previous Close | 0.370 |
| Open | 0.370 |
| Volume | 218,135 |
| Avg. Volume (3M) | 66,959 |
| Market Cap | 45,264,292 |
| Price / Earnings (Forward) | 116.28 |
| Price / Sales | 2.99 |
| Price / Book | 1.82 |
| 52 Weeks Range | |
| Earnings Date | 25 Aug 2025 - 29 Aug 2025 |
| Profit Margin | -47.87% |
| Operating Margin (TTM) | -49.16% |
| Diluted EPS (TTM) | -0.130 |
| Quarterly Revenue Growth (YOY) | 43.00% |
| Total Debt/Equity (MRQ) | 19.39% |
| Current Ratio (MRQ) | 3.99 |
| Operating Cash Flow (TTM) | -12.57 M |
| Levered Free Cash Flow (TTM) | -10.21 M |
| Return on Assets (TTM) | -16.80% |
| Return on Equity (TTM) | -35.20% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (AU) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | CYCLOPHARM FPO [CYC] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Relative Valuation | NA |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | -1.13 |
Select this tab to load the latest available analysis.
|
Cyclopharm Ltd is a health technology company offering solutions related to functional lung ventilation imaging. Its proprietary product Technegas is a broad-spectrum diagnostic lung imaging technology product for the visualisation of pulmonary ventilation and lung function. The company sells its products to healthcare institutions and medical professionals. Maximum revenue is generated from its Technegas products and services, which include the sale of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. Geographically, the company generates maximum revenue from its business in Europe, and the rest from Asia Pacific, Canada, the USA, and other regions. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 48.68% |
| % Held by Institutions | 21.62% |
No data within this time range.
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |